MAZE
Maze Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.6% ·
aandelenstroom +25.2% ·
netto nieuwe posities +8.8%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Plc | 3.14M | n/a | $130.20M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 2.29M | +73.8% | $94.76M | 0.0% | ▲ Add | 3 | SEC ↗ ×10 |
| 3 | The Vanguard Group ✦ (passief) | 1.70M | +27.1% | $70.31M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 4 | Marshall Wace ✦ | 847.47K | +9.0% | $35.11M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Fidelity (FMR) ✦ | 728.61K | +11.1% | $30.19M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passief) | 533.00K | +38.5% | $22.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 527.28K | +11.3% | $21.85M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 448.22K | Nieuw | $18.57M | 0.0% | New | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 258.09K | +21.3% | $10.69M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 10 | Balyasny Asset Management L.P. | 199.21K | n/a | $8.25M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Alyeska Investment Group, L.P. | 196.12K | n/a | $8.13M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Ensign Peak Advisors, Inc | 185.79K | n/a | $7.70M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Northern Trust Corp | 176.26K | n/a | $7.30M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | Charles Schwab Investment… | 175.97K | n/a | $7.29M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 154.47K | Nieuw | $6.40M | 0.0% | New | 1 | SEC ↗ |
| 16 | Invesco Ltd. | 134.03K | n/a | $5.55M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 17 | T. Rowe Price ✦ | 115.71K | +1004.8% | $4.79M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 18 | Goldman Sachs Group ✦ | 114.45K | Nieuw | $4.74M | 0.0% | New | 1 | SEC ↗ ×2 |
| 19 | Ameriprise Financial Inc | 96.69K | n/a | $4.01M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Raymond James Financial Inc | 67.72K | n/a | $2.81M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 21 | Wellington Management ✦ | 61.20K | Nieuw | $2.54M | 0.0% | New | 1 | SEC ↗ ×3 |
| 22 | Bank of New York Mellon Corp | 60.44K | n/a | $2.50M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 23 | Osaic Holdings, Inc. | 59.76K | n/a | $2.48M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Nuveen, LLC | 57.26K | n/a | $2.37M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 25 | Franklin Resources Inc | 55.23K | n/a | $2.29M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 26 | Barclays Plc | 39.51K | n/a | $1.64M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 33.69K | Nieuw | $1.40M | 0.0% | New | 1 | SEC ↗ ×2 |
| 28 | Alliancebernstein L.P. | 33.22K | n/a | $1.38M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 31.30K | n/a | $1.30M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | UBS Group AG | 28.70K | n/a | $1.19M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 31 | AQR Capital Management ✦ | 27.44K | -0.6% | $1.14M | 0.0% | ▼ Trim | 3 | SEC ↗ ×6 |
| 32 | Renaissance Technologies ✦ | 27.10K | -68.5% | $1.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | Tudor Investment Corp Et Al | 24.06K | n/a | $996,764 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Wells Fargo & Company/Mn | 24.01K | n/a | $994,651 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Rhumbline Advisers | 23.73K | n/a | $983,165 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Russell Investments Group, Ltd. | 22.55K | n/a | $934,038 | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 37 | American Century Companies Inc | 21.51K | n/a | $891,118 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 20.01K | +26.8% | $828,890 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 39 | Bank Of America Corp /De/ | 18.38K | n/a | $761,524 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 40 | Deutsche Bank Ag\ | 15.52K | n/a | $643,076 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Citigroup Inc | 11.25K | n/a | $466,171 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 42 | Two Sigma Investments ✦ | 7.25K | -35.0% | $300,160 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 43 | Manufacturers Life Insurance… | 6.90K | n/a | $285,743 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | New York State Common Retirement… | 6.70K | n/a | $277,581 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | ProShare Advisors LLC | 6.05K | n/a | $250,528 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Sei Investments Co | 5.67K | n/a | $234,825 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Bnp Paribas Financial Markets | 5.47K | n/a | $226,746 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Legal & General Group Plc | 5.38K | n/a | $222,852 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 49 | Mirae Asset Global Investments Co.… | 2.34K | n/a | $96,863 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Cwm, Llc | 2.23K | n/a | $92,000 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | California State Teachers… | 1.32K | n/a | $54,729 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Royal Bank Of Canada | 646 | n/a | $27,000 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 53 | Daiwa Securities Group Inc. | 160 | n/a | $7,000 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | UBS AM, a distinct business unit of… | 99 | n/a | $4,102 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Jones Financial Companies Lllp | 90 | n/a | $3,729 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Pnc Financial Services Group, Inc. | 58 | n/a | $2,403 | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Us Bancorp \De\ | 41 | n/a | $1,699 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Citadel Advisors | $18.57M | 0.0% |
| Millennium Management | $6.40M | 0.0% |
| Goldman Sachs Group | $4.74M | 0.0% |
| Wellington Management | $2.54M | 0.0% |
| D. E. Shaw & Co. | $1.40M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 164 houders, 51.62M aandelen, $1.52B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 31.91K aand · $862,186
Officer, Director · 2.59K aand · $70,073
Officer · 16.14K aand · $434,743
Officer · 7.50K aand · $202,921
Officer · 9.71K aand · $254,502
Officer · 59 aand · $1,521
Officer · 5.13K aand · $133,448
Officer, Director · 129 aand · $3,325
Officer, Director · 11.28K aand · $293,482
Officer · 36 aand · $929
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie